H4Plus™ is a patented rumen nutrient that eliminates 80–100% of enteric methane while increasing farm revenue by 62%. The world's first livestock solution that makes farmers richer while eliminating emissions.
Of all global greenhouse gas emissions — livestock methane · The fastest lever for near-term climate impact
Bovaer costs $87 per cow per year and delivers zero productivity gain. Without an economic return, farmers have no reason to adopt it. That's why near-zero uptake followed billions in R&D, FDA approval, and USDA subsidies. The problem isn't the science. It's the economics.
20+ years of applied research by Dr. Kelvin Duncan, former Dean of Science at the University of Canterbury. US Patent 12,263,140 B1 granted April 2025 · 11 months in force. Fast-track examination.
A US dairy farmer pays $75/year for H4Plus™. Their milk revenue increases by 62% per cow per day at a cost of $0.21/day. The investment pays back inside the first month. This is not a compliance cost — it is a profit centre. That's why the sales motion closes on ROI, not regulation.
The farmer registers their farm on Herbi4.com. The platform builds a digital twin — calculating exact product quantities, dosing schedules, and reorder frequency. Product ships with a QR code. The farmer scans it. Verified carbon credits are generated automatically and appear in their dashboard, ready to sell. Zero complexity. Maximum compliance data.
Direct via Herbi4.com + appointed US distributors. Annual per-head recurring. Farmer renews because economics demand it, not regulation.
10% of all carbon credits sold via the linked $HERBI4 platform (separate entity). ~1.75t CO₂e per cow per year × $12–35/tonne. Zero incremental cost to Herbi4. Pure upside not in base case.
Top 50 operators control 80% of volume. One deal = 100K+ animals.
Milk yield uplift is the sales argument. GRAS means immediate availability.
Mandatory Scope 3 reporting from 2025. H4Plus™ is the supply chain instrument.
JBS, Marfrig, Minerva — one enterprise deal = 1M+ animals.
The US is the priority: 26 million feedlot cattle, GRAS status means zero new regulatory approval, and the top 50 operators control 80% of volume. We are in active trial discussions with multiple large ranch operations. UK and EU begin commercial sales in parallel — both markets approved. Brazil enters via enterprise partnership with a major processor.
This isn't a concept. US Patent 12,263,140 B1 was granted April 2025 via fast-track examination. Seven field dairy trials completed. Six sheep trials. Lab fermentation confirmed across all species. The platform is live. The investor demo is ready.
Serial entrepreneur with exits across property, leisure, and technology. Equity in a global cybersecurity company, international payments, and AI banking infrastructure. Full-time at Herbi4: leading go-to-market, international finance, and commercial scale-up.
Former Dean of Science, University of Canterbury. Invented H4Plus™ following 20+ years of applied ruminant biochemistry research beginning with an observation in Japan in 2005. The only person who has spent two decades solving this exact problem.
Former CTO, Bankers Trust Risk Group (now Deutsche Bank). Led the largest global trading system deployment of its era — Credit Suisse First Boston, Merrill Lynch, four of Japan’s largest banks. Built predictive models for the World Economic Forum at Davos, beating every major consultancy. Building Herbi4’s MRV platform and operational infrastructure.
This raise funds simultaneous commercial entry across four approved markets — US, UK, EU, and Brazil. Parallel entry, not sequential. Bigger capital, faster compounding.
This is not a climate investment that requires regulation to pay off. This is a 96% gross margin recurring revenue business with a US patent, proven science, and a sales motion that closes on ROI alone.